The return of Vioxx: Can a drug once deemed deadly be relaunched?

The return of Vioxx: Can a drug once deemed deadly be relaunched?

The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease?

By DAMIAN GARDE

DANIEL HULSHIZER/AP

A drug maker plans to begin a pivotal trial next year and, if the resulting data are positive, apply for approval in hopes of bringing Vioxx back to market.

READ MORE